Advances in TNBC; Mixed News in Lung Cancer Report; Pancreatic Cancer Overdiagnosis?

(MedPage Today) -- A chemotherapy-free regimen of neoadjuvant nivolumab (Opdivo) with or without ipilimumab (Yervoy) induced immune activation in a majority of patients with early triple-negative breast cancer (TNBC) and led to pathologic complete...